UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Obesity treatment will drastically change next few years’
by Lee Han-soo
2019-12-04 18:20
'Insulin is safe, natural replacement therapy for diabetic patients'
by Lee Han-soo
2019-12-04 17:07
SK Biopharm set to ensure superiority in antiepileptic drug
by Jeong Sae-im
2019-12-04 16:18
Hanmi licenses in US firm’s oral immunotherapy candidate
by Lee Han-soo
2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia
by Lee Han-soo
2019-12-04 16:16
라인
Samyang Biopharm’s US subsidiary to work on new immunotherapy
by Jeong Sae-im
2019-12-03 15:37
Ildong signs co-promotion contract with GSK Consumer Healthcare
by Lee Han-soo
2019-12-03 15:18
Global diabetes group opens 5-day show in Busan
by Lee Han-soo
2019-12-03 11:04
LG Chem licenses in US firm’s diagnostic platform tech
by Lee Han-soo
2019-12-02 13:42
Syntekabio views industry’s crisis as opportunity
by Jeong Sae-im
2019-11-29 17:54
라인
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
by Lee Han-soo
2019-11-29 15:42
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
by Jeong Sae-im
2019-11-29 15:23
Hanmi's Chinese partner to start trials for anticancer treatment
by Lee Han-soo
2019-11-28 17:38
GI Innovation licenses out immunotherapy drug candidate to Chinese firm
by Lee Han-soo
2019-11-28 16:26
Takeda's ovarian cancer drug Zejula to get insurance benefit
by Lee Han-soo
2019-11-28 15:36
라인
ST Pharm submits IND application for colorectal cancer treatment in US
by Lee Han-soo
2019-11-28 14:52
New Parkinson’s drug Ongentys lands on Korea
by Jeong Sae-im
2019-11-28 14:52
Experts ascribe excessive diabetes hospitalization to lack of early treatment
by Lee Han-soo
2019-11-28 11:26
Bristol-Myers Squibb Korea names new CEO
by Lee Han-soo
2019-11-28 11:26
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug
by Jeong Sae-im
2019-11-27 18:24
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top